Sartorius Aktiengesellschaft (VIE:SRT3)

Market Cap	15.07B -2.6%
Revenue (ttm)	3.52B +5.8%
Net Income	133.60M +72.2%
EPS	n/a
Shares Out	n/a
PE Ratio	112.81
Forward PE	38.11
Dividend	0.74 (0.28%)
Ex-Dividend Date	Mar 28, 2025

Volume	n/a
Average Volume	17
Open	233.00
Previous Close	236.20
Day's Range	232.90 - 235.10
52-Week Range	172.45 - 275.10
Beta	n/a
RSI	52.21
Earnings Date	Feb 3, 2026

About VIE:SRT3

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Laboratory Analytical Instruments
• Founded: 1870
• Employees: 13,878
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: SRT3

Financial Performance

In 2024, VIE:SRT3's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.